Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Articles published by Morphic Therapeutic Morphic to Participate in Jefferies Global Healthcare Conference May 31, 2024 From Morphic Therapeutic Via GlobeNewswire Tickers MORF Morphic Demonstrates Novel Real-Time Visualization of Small Molecule α4β7 Inhibition of Gut-Trafficking Cells May 21, 2024 From Morphic Therapeutic Via GlobeNewswire Tickers MORF Morphic to Participate in RBC Capital Markets Global Healthcare Conference May 09, 2024 From Morphic Therapeutic Via GlobeNewswire Tickers MORF Morphic Announces Corporate Highlights and Financial Results for the First Quarter 2024 April 25, 2024 From Morphic Therapeutic Via GlobeNewswire Tickers MORF Morphic Appoints Dr. Simon Cooper as Chief Medical Officer March 19, 2024 From Morphic Therapeutic Via GlobeNewswire Tickers MORF Morphic to Participate in March Investor Conferences March 05, 2024 From Morphic Therapeutic Via GlobeNewswire Tickers MORF Morphic Announces Corporate Highlights and Financial Results for the Full Year 2023 February 22, 2024 From Morphic Therapeutic Via GlobeNewswire Tickers MORF Morphic to Present at the 42nd Annual J.P. Morgan Healthcare Conference January 03, 2024 From Morphic Therapeutic Via GlobeNewswire Tickers MORF Morphic to Present at November Investor Conferences November 10, 2023 From Morphic Therapeutic Via GlobeNewswire Tickers MORF Morphic Announces Corporate Highlights and Financial Results for the Third Quarter 2023 November 03, 2023 From Morphic Therapeutic Via GlobeNewswire Tickers MORF Morphic Therapeutic to Host Webcast to Present EMERALD-1 Full Data Set October 09, 2023 From Morphic Therapeutic Via GlobeNewswire Tickers MORF Morphic Holdings Announces CEO Dr. Praveen Tipirneni to Take Temporary Medical Leave of Absence September 26, 2023 From Morphic Therapeutic Via GlobeNewswire Tickers MORF Morphic to Present Positive EMERALD-1 Phase 2a Data for MORF-057 in Patients with Moderate to Severe Ulcerative Colitis in Abstract for UEGW 2023 September 22, 2023 From Morphic Therapeutic Via GlobeNewswire Tickers MORF Morphic Announces Participation in 2023 Wells Fargo Healthcare Conference August 29, 2023 From Morphic Therapeutic Via GlobeNewswire Tickers MORF Morphic to Present at the Canaccord Genuity 43rd Annual Growth Conference August 09, 2023 From Morphic Therapeutic Via GlobeNewswire Tickers MORF Morphic Announces Corporate Highlights and Financial Results for the Second Quarter 2023 August 03, 2023 From Morphic Therapeutic Via GlobeNewswire Tickers MORF Morphic to Present at the Jefferies Global Healthcare Conference June 06, 2023 From Morphic Therapeutic Via GlobeNewswire Tickers MORF Morphic to Present at 2023 RBC Capital Markets Global Healthcare Conference May 12, 2023 From Morphic Therapeutic Via GlobeNewswire Tickers MORF Morphic Presents New Biomarker Data at DDW 2023 Supporting MORF-057 Program in Ulcerative Colitis May 11, 2023 From Morphic Therapeutic Via GlobeNewswire Tickers MORF Morphic Therapeutic Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares May 05, 2023 From Morphic Therapeutic Via GlobeNewswire Tickers MORF Morphic Therapeutic Announces Pricing of $240.0 Million Public Offering May 03, 2023 From Morphic Therapeutic Via GlobeNewswire Tickers MORF Morphic Therapeutic Announces Proposed Public Offering May 02, 2023 From Morphic Therapeutic Via GlobeNewswire Tickers MORF Morphic Reports Positive Topline Results of the EMERALD-1 UC Main Cohort; Orally Administered MORF-057 Achieves Primary Endpoint and Demonstrates Clinically Meaningful Improvements Across Secondary and Exploratory Measures April 25, 2023 From Morphic Therapeutic Via GlobeNewswire Tickers MORF Morphic Announces Corporate Highlights and Financial Results for the First Quarter 2023 April 25, 2023 From Morphic Therapeutic Via GlobeNewswire Tickers MORF Morphic Therapeutic to Host EMERALD-1 Topline Results Call on April 25, 2023 April 24, 2023 From Morphic Therapeutic Via GlobeNewswire Tickers MORF Morphic to Present at TD Cowen 43rd Annual Health Care Conference March 03, 2023 From Morphic Therapeutic Via GlobeNewswire Tickers MORF Morphic Announces Corporate Highlights and Financial Results for the Full Year 2022 February 23, 2023 From Morphic Therapeutic Via GlobeNewswire Tickers MORF Morphic to Present at SVB Leerink Global Healthcare Conference February 14, 2023 From Morphic Therapeutic Via GlobeNewswire Tickers MORF Morphic to Present at the 41st Annual J.P. Morgan Healthcare Conference January 05, 2023 From Morphic Therapeutic Via GlobeNewswire Tickers MORF Morphic Announces Initiation of EMERALD-2 Phase 2b Clinical Trial of MORF-057 in Patients with Moderate-to-Severe Ulcerative Colitis November 22, 2022 From Morphic Therapeutic Via GlobeNewswire Tickers MORF Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
